As part of our new biomedion rebranding strategy, the product name will change from arivis5D to neuronOS. The new brand reinforces the company’s GxP quality, compliance and archiving divisions and enhances the opportunity to grow as an enterprise platform for all types of digital content including images and remains unique in the marketplace.
The name change to neuronOS also reflects our strategy targeted to emphasize collaboration and distributed architectures as a de-facto operating system to leverage innovation along the whole life sciences lifecycle.
biomedion is relaunching neuronos: A Solution for the Pharma Quality
Nov 29, 2021 8:34:16 AM
You may also like
Changes Ahead: Prepare for New FDA Guidance on Annual IND Reporting
Changes Ahead: Prepare for New FDA Guidance on Annual IND Reporting
27 April, 2023Are you ready for the IND (Investigational New Drug) annual reporting major changes? The FDA (Food and Drug Administrati...
Is there a solution to the current data capture gap?
Is there a solution to the current data capture gap?
2 January, 2023Research data capture and cleaning is critical for R&D teams, but it can be time-consuming and prone to errors. The ...
Pharma industry's compliance with OECD GLP Data Integrity guidelines
Pharma industry's compliance with OECD GLP Data Integrity guidelines
7 March, 2023OECD GLP Data Integrity guidelines The Organisation for Economic Co-operation and Development (OECD) issued the latest G...